192 related articles for article (PubMed ID: 30139304)
1. Genomic analysis of the original Elberg Brucella melitensis Rev.1 vaccine strain reveals insights into virulence attenuation.
Salmon-Divon M; Yeheskel A; Kornspan D
Virulence; 2018; 9(1):1436-1448. PubMed ID: 30139304
[TBL] [Abstract][Full Text] [Related]
2. Identification of Brucella melitensis Rev.1 vaccine-strain genetic markers: Towards understanding the molecular mechanism behind virulence attenuation.
Issa MN; Ashhab Y
Vaccine; 2016 Sep; 34(41):4884-4891. PubMed ID: 27595444
[TBL] [Abstract][Full Text] [Related]
3. Transcriptomic analysis of smooth versus rough Brucella melitensis Rev.1 vaccine strains reveals insights into virulence attenuation.
Salmon-Divon M; Kornspan D
Int J Med Microbiol; 2020 Jan; 310(1):151363. PubMed ID: 31699441
[TBL] [Abstract][Full Text] [Related]
4. Genomic Analysis of Natural Rough
Kornspan D; Lubkovskaia R; Mathur S; Yeheskel A; Salmon-Divon M
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33302421
[No Abstract] [Full Text] [Related]
5. Comparison of genomes of Brucella melitensis M28 and the B. melitensis M5-90 derivative vaccine strain highlights the translation elongation factor Tu gene tuf2 as an attenuation-related gene.
Wang F; Qiao Z; Hu S; Liu W; Zheng H; Liu S; Zhao X; Bu Z
Infect Immun; 2013 Aug; 81(8):2812-8. PubMed ID: 23716607
[TBL] [Abstract][Full Text] [Related]
6. Comparative genomic analysis of Brucella melitensis vaccine strain M5 provides insights into virulence attenuation.
Jiang H; Du P; Zhang W; Wang H; Zhao H; Piao D; Tian G; Chen C; Cui B
PLoS One; 2013; 8(8):e70852. PubMed ID: 23967122
[TBL] [Abstract][Full Text] [Related]
7.
Verdiguel-Fernández L; Oropeza-Navarro R; Ortiz A; Robles-Pesina MG; Ramírez-Lezama J; Castañeda-Ramírez A; Verdugo-Rodríguez A
J Microbiol Biotechnol; 2020 Apr; 30(4):497-504. PubMed ID: 31986561
[TBL] [Abstract][Full Text] [Related]
8. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
[TBL] [Abstract][Full Text] [Related]
9. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
[TBL] [Abstract][Full Text] [Related]
10. Rough brucella strain RM57 is attenuated and confers protection against Brucella melitensis.
Feng Y; Peng X; Jiang H; Peng Y; Zhu L; Ding J
Microb Pathog; 2017 Jun; 107():270-275. PubMed ID: 28390976
[TBL] [Abstract][Full Text] [Related]
11. Development of Brucella melitensis Rev.1 ΔOmp19 mutants with DIVA feature and comparison of their efficacy against three commercial vaccines in a mouse model.
Uslu A; Erganis O
Mol Immunol; 2021 May; 133():44-52. PubMed ID: 33631554
[TBL] [Abstract][Full Text] [Related]
12. Transcriptomic Analysis of the
Salmon-Divon M; Zahavi T; Kornspan D
Front Microbiol; 2019; 10():250. PubMed ID: 30837973
[TBL] [Abstract][Full Text] [Related]
13. Development and evaluation as vaccines in mice of Brucella melitensis Rev.1 single and double deletion mutants of the bp26 and omp31 genes coding for antigens of diagnostic significance in ovine brucellosis.
Cloeckaert A; Jacques I; Grilló MJ; Marín CM; Grayon M; Blasco JM; Verger JM
Vaccine; 2004 Jul; 22(21-22):2827-35. PubMed ID: 15246618
[TBL] [Abstract][Full Text] [Related]
14. The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.
Wang Y; Bai Y; Qu Q; Xu J; Chen Y; Zhong Z; Qiu Y; Wang T; Du X; Wang Z; Yu S; Fu S; Yuan J; Zhen Q; Yu Y; Chen Z; Huang L
Vet Microbiol; 2011 Aug; 151(3-4):354-62. PubMed ID: 21530111
[TBL] [Abstract][Full Text] [Related]
15. Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice.
Tibor A; Jacques I; Guilloteau L; Verger JM; Grayon M; Wansard V; Letesson JJ
Infect Immun; 1998 Nov; 66(11):5561-4. PubMed ID: 9784574
[TBL] [Abstract][Full Text] [Related]
16. Vaccine Candidate Brucella melitensis 16M
Hensel ME; Garcia-Gonzalez DG; Chaki SP; Hartwig A; Gordy PW; Bowen R; Ficht TA; Arenas-Gamboa AM
mSphere; 2020 May; 5(3):. PubMed ID: 32404509
[TBL] [Abstract][Full Text] [Related]
17. Complete genome sequences of Brucella melitensis strains M28 and M5-90, with different virulence backgrounds.
Wang F; Hu S; Gao Y; Qiao Z; Liu W; Bu Z
J Bacteriol; 2011 Jun; 193(11):2904-5. PubMed ID: 21478357
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
[TBL] [Abstract][Full Text] [Related]
19. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
[TBL] [Abstract][Full Text] [Related]
20. Comparative genomic analysis of Brucella abortus vaccine strain 104M reveals a set of candidate genes associated with its virulence attenuation.
Yu D; Hui Y; Zai X; Xu J; Liang L; Wang B; Yue J; Li S
Virulence; 2015; 6(8):745-54. PubMed ID: 26039674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
